Anna-Lena Frisk - Global Drug Discovery Global Early Dev, Bayer Healthcare

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 31 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Data from Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity

Antje M. Wengner,Gerhard Siemeister, Marcus Koppitz,Volker Schulze,Dirk Kosemund,Ulrich Klar, Detlef Stoeckigt,Roland Neuhaus, Philip Lienau,Benjamin Bader,Stefan Prechtl,Marian Raschke,

crossref（2023）

Cited0Views0Bibtex

European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development

Josep M Monné Rodríguez,Anna-Lena Frisk, Robert Kreutzer, Thomas Lemarchand, Stephane Lezmi,Chandrassegar Saravanan,Birgit Stierstorfer, Céline Thuilliez,Enrico Vezzali, Grazyna Wieczorek, Seong-Wook Yun,Dirk Schaudien

Toxicologic pathologyno. 3 (2023): 1926233231178282-111

Cited0Views0WOSBibtex

Artificial Intelligence In Toxicologic Pathology: Quantitative Evaluation Of Compound-Induced Hepatocellular Hypertrophy In Rats

Hannah Pischon,David Mason,Bettina Lawrenz,Olivier Blanck,Anna-Lena Frisk,Frederic Schorsch,Valeria Bertani

TOXICOLOGIC PATHOLOGY（2021）

Cited12Views0WOSBibtex

Publication Categories In Toxicologic Pathology

Molly H Boyle,Bindu Bennet,Karyn Colman,Anna-Lena Frisk,Begonya Garcia,Christopher D Houle,Annette Romeike,Radhakrishna Sura,Jonathan Werner,Susan A Elmore

TOXICOLOGIC PATHOLOGY（2021）

Cited0Views0WOSBibtex

Characterization of BAY 1905254, an immune checkpoint inhibitor targeting the immunoglobulin-like domain containing receptor 2 (ILDR2)

Julia Huetter,Uwe Gritzan,Ilona Gutcher,Wolf-Dietrich Doecke,Merlin V Luetke-Eversloh,Sven Golfier,Helge G Roider,Anna-Lena Frisk,John Hunter, Andrew Pow,Andrew Drake,Zurit Levine,

CANCER IMMUNOLOGY RESEARCH（2020）

Cited9Views0WOSBibtex

Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG

Inge A Ivens, David Banczyk,Katrin Gutberlet, Shawna Jackman, Stéphanie Vauléon,Anna-Lena Frisk

TOXICOLOGIC PATHOLOGY（2019）

Cited2Views0WOSBibtex

Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays

E Schmid, M Klotz, K Steiner-Hahn, T Konen,A L Frisk, C Schatz,T Krahn,O von Ahsen

BIOTECHNIC & HISTOCHEMISTRY（2017）

Cited4Views0WOSBibtex

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents

Jessica Lohrke,Anna-Lena Frisk,Thomas Frenzel,Laura Schöckel,Martin Rosenbruch,Gregor Jost,Diana Constanze Lenhard,Martin A Sieber,Volker Nischwitz,Astrid Küppers,Hubertus Pietsch

Investigative radiologyno. 6 (2017): 324-333

Cited153Views0WOSBibtex

153

Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity

Antje M Wengner,Gerhard Siemeister,Marcus Koppitz,Volker Schulze,Dirk Kosemund,Ulrich Klar,Detlef Stoeckigt,Roland Neuhaus,Philip Lienau,Benjamin Bader,Stefan Prechtl,Marian Raschke,

MOLECULAR CANCER THERAPEUTICS（2016）

Cited74Views0WOSBibtex

Preclinical Pharmacology And Repeated Dose Toxicity Of The Novel Agonistic Receptor Binding Antibody Bay-356

Sandra Berndt,Christian Votsmeier,Ruprecht Zierz, Jakob Walter,Anna-Lena Frisk,Stefanie Hammer,Heiner Apeler,Bertolt Kreft

CANCER RESEARCH（2016）

Cited2Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn